Thomas Peter Kalmbach Sells 21,000 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 21,000 shares of the stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the sale, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,105,274.08. This trade represents a 29.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Tuesday, July 28th, Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00.
• On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24.
• On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total value of $1,864,128.83.
• On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80.
• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05.

Globe Life Price Performance

GL opened at $182.14 on Friday. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55. The firm has a market cap of $14.14 billion, a price-to-earnings ratio of 12.09 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The company has a fifty day simple moving average of $171.52 and a 200 day simple moving average of $154.26.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the company earned $3.05 earnings per share. The company’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities research analysts expect that Globe Life Inc. will post 15.7 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Hilton Head Capital Partners LLC acquired a new position in Globe Life during the 4th quarter worth $30,000. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life in the 2nd quarter worth approximately $28,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the second quarter worth $31,000. Torren Management LLC acquired a new stake in Globe Life during the fourth quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc grew its position in Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the period. 81.61% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on GL. Wells Fargo & Company raised their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. Keefe, Bruyette & Woods decreased their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research note on Friday, July 24th. Piper Sandler raised their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Morgan Stanley boosted their price target on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.